Fig. 2
From: Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Distribution of cytokines scores of the change from start of treatment to 16 weeks after the start of treatment by autoantibodies
Fig. 2 | BMC Musculoskeletal Disorders